KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Net Margin: 2010-2024

Historic Net Margin for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to -18.26%.

  • Emergent BioSolutions' Net Margin fell 1692.00% to 22.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.62%, marking a year-over-year increase of 3230.00%. This contributed to the annual value of -18.26% for FY2024, which is 5421.00% up from last year.
  • As of FY2024, Emergent BioSolutions' Net Margin stood at -18.26%, which was up 74.80% from -72.48% recorded in FY2023.
  • Emergent BioSolutions' 5-year Net Margin high stood at 19.39% for FY2020, and its period low was -72.48% during FY2023.
  • Over the past 3 years, Emergent BioSolutions' median Net Margin value was -18.94% (recorded in 2022), while the average stood at -36.56%.
  • Per our database at Business Quant, Emergent BioSolutions' Net Margin plummeted by 5,354bps in 2023 and then surged by 5,421bps in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Net Margin stood at 19.39% in 2020, then tumbled by 701bps to 12.38% in 2021, then tumbled by 3,131bps to -18.94% in 2022, then tumbled by 5,354bps to -72.48% in 2023, then skyrocketed by 5,421bps to -18.26% in 2024.